IQVIA HOLDINGS INC. Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax
IQVIA HOLDINGS INC. (IQV) reported Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax of $11.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-19.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax · last filed 2019-02-19
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for the quarter ending 2018-12-31 was $11.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for the quarter ending 2018-09-30 was $1.00M, a 50.00% decline year-over-year.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for the quarter ending 2018-06-30 was $1.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for the quarter ending 2018-03-31 was -$2.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for fiscal 2018 was $11.00M, a 1000.00% increase from fiscal 2017.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for fiscal 2017 was $1.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for fiscal 2016 was -$28.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for fiscal 2015 was -$18.00M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 3 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 6 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 9 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 12 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $11.00M derived: 10-K 12 month − 3 quarters · filed 2019-02-19 | $12.00M derived: sum of 2 quarters · filed 2019-02-19 | $13.00M derived: sum of 3 quarters · filed 2019-02-19 | $11.00M 10-K · filed 2019-02-19 | ||||
| 2018-09-30 | $1.00M 10-Q · filed 2018-10-25 | $2.00M derived: sum of 2 quarters · filed 2018-10-25 | $0.00 derived: sum of 3 quarters · filed 2018-10-25 | |||||
| 2018-06-30 | $1.00M 10-Q · filed 2018-07-27 | -$1.00M 10-Q · filed 2018-07-27 | ||||||
| 2018-03-31 | -$2.00M 10-Q · filed 2018-05-04 | |||||||
| 2017-12-31 | $1.00M 10-K · filed 2019-02-19 | |||||||
| 2017-09-30 | $2.00M 10-Q · filed 2018-10-25 | $2.00M derived: sum of 2 quarters · filed 2018-10-25 | $0.00 derived: sum of 3 quarters · filed 2018-10-25 | -$10.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$2.00M 10-Q · filed 2018-07-27 | -$12.00M derived: sum of 3 quarters · filed 2019-02-19 | -$21.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-03-31 | -$2.00M 10-Q · filed 2018-05-04 | -$12.00M derived: sum of 2 quarters · filed 2019-02-19 | -$21.00M derived: sum of 3 quarters · filed 2019-02-19 | -$24.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2016-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$19.00M derived: sum of 2 quarters · filed 2019-02-19 | -$22.00M derived: sum of 3 quarters · filed 2019-02-19 | -$28.00M 10-K · filed 2019-02-19 | ||||
| 2016-09-30 | -$9.00M 10-Q · filed 2017-10-27 | -$7.66M 10-Q · filed 2016-11-03 | -$12.00M derived: sum of 2 quarters · filed 2017-10-27 | -$18.00M 10-Q · filed 2017-10-27 | -$17.59M 10-Q · filed 2016-11-03 | -$21.43M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | -$3.00M 10-Q · filed 2017-08-04 | -$3.59M 10-Q · filed 2016-07-27 | -$9.00M 10-Q · filed 2017-08-04 | -$9.93M 10-Q · filed 2016-07-27 | -$12.43M derived: sum of 3 quarters · filed 2018-02-16 | -$16.42M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | -$6.00M 10-Q · filed 2017-05-08 | -$6.34M 10-Q · filed 2016-05-03 | -$9.43M derived: sum of 2 quarters · filed 2018-02-16 | -$13.42M derived: sum of 3 quarters · filed 2018-02-16 | -$18.51M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | -$3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$7.42M derived: sum of 2 quarters · filed 2018-02-16 | -$12.51M derived: sum of 3 quarters · filed 2018-02-16 | -$18.00M 10-K · filed 2018-02-16 | -$18.27M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | -$3.99M 10-Q · filed 2016-11-03 | -$9.08M derived: sum of 2 quarters · filed 2016-11-03 | -$14.57M 10-Q · filed 2016-11-03 | -$19.01M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | -$5.09M 10-Q · filed 2016-07-27 | -$10.58M 10-Q · filed 2016-07-27 | -$15.02M derived: sum of 3 quarters · filed 2017-02-16 | -$17.56M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | -$5.49M 10-Q · filed 2016-05-03 | -$9.93M derived: sum of 2 quarters · filed 2017-02-16 | -$12.47M derived: sum of 3 quarters · filed 2017-02-16 | -$13.32M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | -$4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$6.97M derived: sum of 2 quarters · filed 2017-02-16 | -$7.83M derived: sum of 3 quarters · filed 2017-02-16 | -$9.00M 10-K · filed 2017-02-16 | -$8.63M 10-K · filed 2016-02-11 | |||
| 2014-09-30 | -$2.54M 10-Q · filed 2015-10-28 | -$3.39M derived: sum of 2 quarters · filed 2015-10-28 | -$4.56M 10-Q · filed 2015-10-28 | |||||
| 2014-06-30 | -$857.00K 10-Q · filed 2015-07-29 | -$2.03M 10-Q · filed 2015-07-29 | ||||||
| 2013-12-31 | -$13.08M 10-K · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |